Published in Hum Immunol on November 01, 1981
Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc Natl Acad Sci U S A (1986) 1.64
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol (2004) 0.93
Antigen presentation by a subset of T8+ Ia+ cells to T4+ helper cells. Clin Exp Immunol (1987) 0.93
The permeability of the blood-brain barrier in mice suffering from fatal lymphocytic choriomeningitis virus infection. Acta Neuropathol (1984) 0.92
The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation. PLoS One (2013) 0.84
Endothelial microparticles interact with and support the proliferation of T cells. J Immunol (2014) 0.80
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
Beta-D-fructofuranoside fructohydrolase from yeast. Methods Enzymol (1975) 9.19
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 9.06
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 3.81
Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (1982) 3.80
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Health of the public. The academic response. Health of the Public Mission Statement Working Group. JAMA (1992) 2.95
Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br J Pharmacol (1973) 2.93
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene (1995) 2.91
Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A (1971) 2.82
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet (1997) 2.77
Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci U S A (1979) 2.66
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proc Natl Acad Sci U S A (1981) 2.53
A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci (1975) 2.34
Undetected eye disease in a primary care clinic population. Arch Intern Med (1994) 2.32
Can health visitors prevent fractures in elderly people? BMJ (1992) 2.25
Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care (2000) 2.23
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proc Natl Acad Sci U S A (1976) 2.16
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med (2000) 1.95
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Genetics of coeliac disease. QJM (1996) 1.90
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
Bloodstream infections in the elderly. Am J Med (1989) 1.80
Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol (1988) 1.76
Trendelenburg position and passive leg raising do not significantly improve cardiopulmonary performance in the anesthetized patient with coronary artery disease. Crit Care Med (1989) 1.75
Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc Natl Acad Sci U S A (1981) 1.74
Tolerance to opioid narcotics. I. Tolerance to the "running fit" caused by levorphanol in the mouse. J Pharmacol Exp Ther (1969) 1.73
Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther (1969) 1.72
Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet (1994) 1.71
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.68
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 1.68
A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sci (1980) 1.67
Filters on the pathway to mental health care, II. Sociodemographic factors. Psychol Med (1995) 1.66
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ (1992) 1.63
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Problems in diagnosis and management of desmoid tumors. Am J Surg (1990) 1.56
Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Ann Intern Med (1985) 1.53
Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med (1993) 1.53
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Limited capacity for protein synthesis at zero degrees centigrade in Escherichia coli. J Mol Biol (1968) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr (1996) 1.51
Evaluation of a method for counting absolute numbers of cells with a flow cytometer. Clin Diagn Lab Immunol (1997) 1.51
Opioid peptides endorphins in pituitary and brain. Science (1976) 1.50
Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47
Primary care physicians' views on access and health care reform: the situation in North Carolina. J Fam Pract (1993) 1.46
Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke (2001) 1.46
Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood (2001) 1.45
Imaging of pelvic postpartum complications. AJR Am J Roentgenol (1997) 1.44
A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sci (1975) 1.44
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Inhibition by chlorampenicol of the growth of nascent protein chains in Escherichia coli. Mol Pharmacol (1966) 1.43
Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A (1985) 1.40
Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys. Int J Cancer (1996) 1.40
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Transcranial sonography through the burr hole for detection of ventriculomegaly. A preliminary report. J Ultrasound Med (1991) 1.39
Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects. Clin Pharmacol Ther (2012) 1.39
Training in international animal health. Vet Rec (2001) 1.38
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
The mechanism of antigen presentation by endothelial cells. Immunobiology (1984) 1.37
Ligand dissociation constants from competition binding assays: errors associated with ligand depletion. Mol Pharmacol (1987) 1.36
Inherited susceptibility to breast cancer. Cancer Surv (1993) 1.36
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet (1998) 1.35
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) (1988) 1.35
Immunoreactive dynorphin in pituitary and brain. Proc Natl Acad Sci U S A (1980) 1.33
Expression of I-region-associated antigen (Ia) and interleukin 1 by subcultured human endothelial cells. Cell Immunol (1985) 1.33
Look After Your Heart programme: impact on health status, exercise knowledge, attitudes, and behaviour of retired women in England. J Epidemiol Community Health (1994) 1.32
Experimental determination of baseball spin and lift. J Sports Sci (2001) 1.31
Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature (1981) 1.30
Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. Am J Hum Genet (1993) 1.29
ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. J Gen Physiol (1943) 1.29
Early open reduction and internal fixation of the disrupted pelvic ring. J Trauma (1986) 1.29
Menopausal symptoms in a hospital-based sample of women in southern Thailand. Climacteric (2006) 1.26
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Morphine and other opiates from beef brain and adrenal. Proc Natl Acad Sci U S A (1985) 1.26
Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol Pharmacol (1984) 1.25
HLA associations in sarcoidosis: a study of two ethnic groups. Thorax (1984) 1.25
Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature (1971) 1.24
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet (1995) 1.24